AIMS/HYPOTHESIS: Genetic variation in OCT1 can influence the glycemic response to metformin. We evaluated the effects of the OCT1 single-nucleotide polymorphisms (SNPs), rs1867351, rs4709400, rs628031, and rs2297374, on metformin efficacy in type-2 diabetes mellitus (DM) patients. METHODS: We performed a single-center prospective analysis of the distributions of these SNPs in a cohort of Han Chinese subjects in Shanghai, China (HCS), and evaluated the effects of each SNP on glycemic control in HCS DM patients following 3 months of incident metformin treatment. RESULTS: The allele frequencies of rs4709400 and rs628031 in our HCS control group differed from those previously reported for Han Chinese subjects in Beijing (HCB), as well as those previously reported for Caucasians and Africans, whereas the allele frequencies of rs1867351 and rs2297374 were more similar to those in HCB subjects. The DM patients with the rs1867351 T/T or rs4709400 G/G genotype exhibited greater reductions in postprandial plasma glucose (PPG), compared to those with different genotypes of these SNPs. The DM patients with the rs2297374 C/T, rs4709400 G/G, or rs628031 G/G genotype exhibited greater reductions in fasting plasma glucose (FPG), and those with the rs1867351 T/T, rs628031 A/A, or rs2297374 C/T genotype exhibited greater reductions in HbA1c , compared to those with different genotypes of these SNPs. Conclusions /interpretation: The rs1867351, rs4709400, rs628031, and rs2297374 SNPs of OCT1 have selective effects on FPG, PPG, and HbA1c in HCS DM patients in response to metformin treatment. Future studies of these SNPs in larger samples of HCS DM patients are warranted.
AIMS/HYPOTHESIS: Genetic variation in OCT1 can influence the glycemic response to metformin. We evaluated the effects of the OCT1 single-nucleotide polymorphisms (SNPs), rs1867351, rs4709400, rs628031, and rs2297374, on metformin efficacy in type-2 diabetes mellitus (DM) patients. METHODS: We performed a single-center prospective analysis of the distributions of these SNPs in a cohort of Han Chinese subjects in Shanghai, China (HCS), and evaluated the effects of each SNP on glycemic control in HCS DMpatients following 3 months of incident metformin treatment. RESULTS: The allele frequencies of rs4709400 and rs628031 in our HCS control group differed from those previously reported for Han Chinese subjects in Beijing (HCB), as well as those previously reported for Caucasians and Africans, whereas the allele frequencies of rs1867351 and rs2297374 were more similar to those in HCB subjects. The DMpatients with the rs1867351 T/T or rs4709400 G/G genotype exhibited greater reductions in postprandial plasma glucose (PPG), compared to those with different genotypes of these SNPs. The DMpatients with the rs2297374 C/T, rs4709400 G/G, or rs628031 G/G genotype exhibited greater reductions in fasting plasma glucose (FPG), and those with the rs1867351 T/T, rs628031 A/A, or rs2297374 C/T genotype exhibited greater reductions in HbA1c , compared to those with different genotypes of these SNPs. Conclusions /interpretation: The rs1867351, rs4709400, rs628031, and rs2297374 SNPs of OCT1 have selective effects on FPG, PPG, and HbA1c in HCS DMpatients in response to metformin treatment. Future studies of these SNPs in larger samples of HCS DMpatients are warranted.
Authors: S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews Journal: Diabetologia Date: 2012-04-20 Impact factor: 10.122
Authors: M V Tzvetkov; S V Vormfelde; D Balen; I Meineke; T Schmidt; D Sehrt; I Sabolić; H Koepsell; J Brockmöller Journal: Clin Pharmacol Ther Date: 2009-06-17 Impact factor: 6.875
Authors: Mette M H Christensen; Charlotte Brasch-Andersen; Henrik Green; Flemming Nielsen; Per Damkier; Henning Beck-Nielsen; Kim Brosen Journal: Pharmacogenet Genomics Date: 2011-12 Impact factor: 2.089
Authors: I Tkáč; L Klimčáková; M Javorský; M Fabianová; Z Schroner; H Hermanová; E Babjaková; R Tkáčová Journal: Diabetes Obes Metab Date: 2012-09-09 Impact factor: 6.577
Authors: N van Leeuwen; G Nijpels; M L Becker; H Deshmukh; K Zhou; B H C Stricker; A G Uitterlinden; A Hofman; E van 't Riet; C N A Palmer; B Guigas; P E Slagboom; P Durrington; R A Calle; A Neil; G Hitman; S J Livingstone; H Colhoun; R R Holman; M I McCarthy; J M Dekker; L M 't Hart; E R Pearson Journal: Diabetologia Date: 2012-03-28 Impact factor: 10.122
Authors: Patrick J O'Connor; William A Rush; Gestur Davidson; Thomas A Louis; Leif I Solberg; Lauren Crain; Paul E Johnson; Robin R Whitebird Journal: Prev Chronic Dis Date: 2007-12-15 Impact factor: 2.830
Authors: Yulia A Nasykhova; Ziravard N Tonyan; Anastasiia A Mikhailova; Maria M Danilova; Andrey S Glotov Journal: Int J Mol Sci Date: 2020-09-18 Impact factor: 5.923